Health
Synthetic Nanobodies Identified That Neutralize SARS-CoV-2 – Anti Aging News
ACE2 has become the key target of COVID-19 therapeutics investigating interrupting the interaction between the spike protein on the SARS-CoV-2 virus and its receptor…
ACE2 has become the key target of COVID-19 therapeutics investigating interrupting the interaction between the spike protein on the SARS-CoV-2 virus and its receptor on host cells; recent work published in Nature Communications suggests that a synthetic nanobody, sybodies, has been found that can neutralize SARS-CoV-2 constituting a potential treatment. The group of researchers are reporting the rapid isolation and characterization of nanobodies from a synthetic library called sybodies that target…
-
General13 hours agoFrom Humpty Doo to the bush, these voters’ views reflect the challenge for federal politicians
-
General11 hours agoNew Zealand wants more ‘automated decision-making’ in its welfare system. Could that lead to Robodebt 2.0?
-
Noosa News13 hours agoThe Pedro Pascal-Led Fantastic Four Face Julia Garner’s Silver Surfer in the New Full ‘First Steps’ Trailer
-
Noosa News16 hours agoQueensland set for ‘comfortable’ weather over Easter long weekend